Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS).

Christina L. Roland,Emily Z. Keung,Alexander J. Lazar,Keila E. Torres,Wei Lien Wang,Ashleigh Guadagnolo,Andrew J. Bishop,Heather Lin,Kelly K. Hunt,Barry W. Feig,Justin E. Bird,Valerae O. Lewis,Hussein Abdul-Hassan Tawbi,Ravin Ratan,Shreyaskumar Patel,Jennifer A. Wargo,Neeta Somaiah

Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS).

2020

Christina L. Roland
Emily Z. Keung
Alexander J. Lazar
Keila E. Torres
Wei Lien Wang
Ashleigh Guadagnolo
Andrew J. Bishop
Heather Lin
Kelly K. Hunt
Barry W. Feig
Justin E. Bird
Valerae O. Lewis
Hussein Abdul-Hassan Tawbi
Ravin Ratan
Shreyaskumar Patel
Jennifer A. Wargo
Neeta Somaiah

11505Background: is a randomized, phase II non-comparative trial evaluating the efficacy of neoadjuvant checkpoint blockade [nivolumab (N) or ipilimumab/ nivolumab (I/N)] in patients (pts) with sur...

Keywords:

Blockade
Dedifferentiated liposarcoma
Phases of clinical research
Pathology
Undifferentiated Pleomorphic Sarcoma
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations